Articles from D. Boral Capital

ONTARIO, Calif., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Nature's Miracle Holding, Inc. (Nasdaq: NMHI) ("Nature's Miracle"), a growing agriculture technology company providing equipment and services to growers, announced that it entered into a Securities Purchase Agreement ("SPA") with a single institutional investor ("Investor") on January 10, 2025. The SPA allows Nature's Miracle, subject to customary conditions, to sell up to $29.7 million in the aggregate of a newly-designated class of convertible preferred stock to the Investor.

BETHESDA, Md., Jan. 07, 2025 (GLOBE NEWSWIRE) -- HWH International Inc. (the “Company”) (NASDAQHWH), a purpose-driven lifestyle company, today announced the closing of its public offering (the “Offering”) with aggregate gross proceeds to the Company of $1,764,900, prior to deducting fees and other expenses payable by the Company. The Offering consisted of 3,412,500 shares of common stock and 1,000,000 pre-funded warrants to purchase 1,000,000 shares of common stock. Each share of common stock (or pre-funded warrant in lieu thereof) was sold at a purchase price of $0.40 per share (or $0.3999 per pre-funded warrant after reducing $0.0001 attributable to the exercise price of the pre-funded warrants).

WUXI, China, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Park Ha Biological Technology Co., Ltd. (the "Company"), a company focused on developing private skincare labels, direct skincare product sales, and franchise alliance promotions, today announced the pricing of its initial public offering (the "Offering") of 1,200,000 ordinary shares at a public offering price of $4.00 per ordinary share. The ordinary shares have been approved for listing on the Nasdaq Capital Market and are expected to commence trading on December 27, 2024 under the ticker symbol "PHH."

HOUSTON, Dec. 30, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics”), a clinical-stage biotechnology company with 160+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, announced that it has entered into a Standby Equity Purchase Agreement (the “SEPA”) with YA II PN LTD. (“Yorkville”), an investment fund managed by Yorkville Advisors Global, LP. The agreement allows FibroBiologics, subject to customary conditions, to sell up to $25 million in the aggregate of its common stock to Yorkville over the course of two years.

NEW YORK, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Webuy Global Ltd (Nasdaq: WBUY) (the “Company”), a Southeast Asian community-oriented e-commerce retailor with a focus on grocery and travel, on December 17, 2024, announced the closing of its previously announced registered direct offering with certain institutional investors for the sale and purchase of an aggregate of 21,013,239 of the Company’s Class A ordinary shares, par value $0.000000385 per share (the “Shares”) (or Class A ordinary share equivalents in lieu thereof) in a registered direct offering at a purchase price of $0.1756 per share. The purchase price for the pre-funded warrants is $0.1755 to the purchase price for Shares, less the exercise price of $0.0001 per share.

FORT LAUDERDALE, Fla., Dec. 16, 2024 (GLOBE NEWSWIRE) -- FAVO Capital, Inc. (OTC PINK:FAVO), a leading provider of alternative financing solutions in the Private Credit Sector, today announced that it has entered into securities purchase agreements with certain investors to purchase 8,000,000 shares of common stock and warrants to purchase up to 8,000,000 shares of common stock, at a purchase price of $0.25 per share and accompanying warrant. The gross proceeds to the Company from the private placement are expected to be approximately $2.0 million before deducting the placement agent's fees and other estimated offering expenses. The warrants will be immediately exercisable from the date of issuance at an initial exercise price of $0.40 per share, subject to adjustments as set forth therein, and will expire five years from the date of issuance. The closing of the private placement occurred on December 11, 2024, subject to the satisfaction of certain customary closing conditions set forth in the securities purchase agreement.

CULVER CITY, Calif., Dec. 12, 2024 (GLOBE NEWSWIRE) -- ImmunityBio, Inc. (NASDAQIBRX), a leading immunotherapy company, today announced the pricing of its previously announced underwritten public offering of an aggregate of 33,333,334 shares of its common stock at a price to the public of $3.00 per share. ImmunityBio has granted the underwriters a 30-day option to purchase up to an additional 5,000,000 shares of its common stock at the public offering price, less underwriting discounts and commissions. All of the shares were sold by ImmunityBio. Before deducting the underwriting discount and offering expenses payable by ImmunityBio, ImmunityBio expects to receive gross proceeds of approximately $100.0 million, assuming no exercise of the underwriters’ option to purchase additional shares. The offering is expected to close on or about December 12, 2024 subject to satisfaction of customary closing conditions.

NEW YORK, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Baijiayun Group Ltd ("Baijiayun" or the "Company") (NASDAQRTC), a one-stop AI video solution provider, on December 6, 2024, announced that it has entered into a Standby Equity Purchase Agreement (the "SEPA"), with YA II PN, Ltd. ("YA"), a fund managed by Yorkville Advisors Global, LP. Subject to the terms and conditions set forth in the the SEPA, YA is committed to purchase up to $50 million (the "Commitment Amount") of the Company's Class A Ordinary Shares (the "Shares") at any time during the two-year period following the execution date of the SEPA, by delivering written notice to YA (an "Advance Notice"). Pursuant to the SEPA, YA will advance to the Company, subject to the satisfaction of certain conditions as set forth therein, the principal amount of up to $15 million (the "Pre-Paid Advance"), which will be evidenced by convertible promissory notes (the "Promissory Notes", together with the "SEPA", the "Offering") in four tranches. The first Pre-Advance, in the principal amount of $3,000,000, was advanced December 6, 2024 in connection with the execution of the SEPA, and is subject to a 10% discount to the principal amount of such Promissory Note.

NEW YORK, Dec. 03, 2024 (GLOBE NEWSWIRE) -- On November 27, 2024, Wing Yip Food Holdings Group Limited (the “Company” or “Wing Yip”) (Nasdaq: WYHG), a meat product processing company through its operating subsidiaries in mainland China, announced the closing of its initial public offering (the “Offering”) of 2,050,000 American Depositary Shares (“ADSs”) at a public offering price of US$4.00 per ADS. Each ADS represents one ordinary share of the Company. The Offering was conducted on a firm commitment basis. The ADSs commenced trading on the Nasdaq Capital Market on November 26, 2024 under the ticker symbol “WYHG”.

NEW YORK, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Armlogi Holding Corp. (“Armlogi” or the “Company”) (Nasdaq: BTOC), a U.S.-based warehousing and logistics service provider that offers a comprehensive package of supply-chain solutions related to warehouse management and order fulfillment, on November 25, 2024 announced that it has entered into a Standby Equity Purchase Agreement (the “SEPA”) with YA II PN, Ltd. (“YA”), a fund managed by Yorkville Advisors Global, LP. Pursuant to the terms of the SEPA, YA is committed to purchase up to $50 million (the “Commitment Amount”) of the Company’s common stock (the “Common Stock”) at any time during the two-year period following the execution date of the SEPA, by delivering written notice to YA (an “Advance Notice”). Pursuant to the SEPA, YA will advance to the Company, subject to the satisfaction of certain conditions as set forth therein, the principal amount of $21 million (the “Pre-Paid Advance”), which will be evidenced by convertible promissory notes (the “Promissory Notes”, together with the “SEPA”, the “Offering”) in three tranches. The Company has received an initial Pre-Paid Advance of $5 million in connection with the execution of the SEPA.

COSTA MESA, Calif., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Real Messenger Holdings Limited (“Real Messenger” or the “Company”), an innovative chat-based platform reimagining real estate connections, and Nova Vision Acquisition Corp. (“Nova Vision”) (Nasdaq: NOVV, NOVVR, NOVVW and NOVVU), a special purpose acquisition company (“SPAC”), announced today the completion of their previously announced business combination (the “Business Combination”). The combined company will operate under the name Real Messenger Corporation and is set to begin trading on Nasdaq under the ticker symbols “RMSG” and “RMSGW” on November 20, 2024. The Business Combination, approved at a special meeting of Nova Vision shareholders on September 12, 2024, signals a new phase in Real Messenger’s journey to empower the real estate industry with advanced digital solutions.

DURHAM, N.C., Nov. 22, 2024 (GLOBE NEWSWIRE) -- 374Water Inc. (NASDAQSCWO), a global leader in organic waste destruction technology for the municipal, federal, and industrial markets, today announced that it entered into a securities purchase agreement with certain investors to purchase approximately $12.2 million worth of its common stock and warrants in a registered direct offering. Under the terms of the securities purchase agreement, the Company has agreed to sell 9,783,496 shares of its common stock, par value $0.0001 ("Common Stock") and warrants ("Warrants") to purchase 14,675,244 shares of Common Stock. The Warrants will be exercisable immediately upon issuance, have an exercise price of $1.125 per share, and will expire five years from the initial exercise date. The purchase price for one share of Common Stock and accompanying 1.5 Warrants will be $1.25.

NEW YORK, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Nature's Miracle Holding Inc. (NASDAQNMHI) ("Nature's Miracle" or the "Company"), on November 12, 2024 closed its previously announced underwritten public offering of (a) 25,133,631 units (the "Units"), with each Unit consisting of (i) one share of common stock, par value $0.0001 per share (the "Common Stock"), (ii) one Series A Warrant to purchase one share of Common Stock (the "Series A Warrant"), and (iii) one Series B Warrant to purchase such number of shares of Common Stock as determined on the Reset Date (as defined in the Series B Warrant) (the "Series B Warrant"), at a public offering price of $0.1118 per Unit and (b) 1,700,000 pre-funded units (the "Pre-Funded Units"), with each Pre-Funded Unit consisting of (i) one pre-funded warrant exercisable for one share of Common Stock, (ii) one Series A Warrant, and (iii) one Series B Warrant, at a public offering price of $0.1117 per Pre-Funded Unit, for the aggregate gross proceeds of approximately $3 million, prior to deducting underwriting discounts and other offering expenses.

NEW YORK, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5) (“Aduro” or the “Company”), a clean technology company using the power of chemistry to transform lower value feedstocks like waste plastics, heavy bitumen, and renewable oils into resources for the 21st century, announced on November 8, 2024 the closing of its underwritten U.S. public offering (the “Offering”) of 941,177 common shares at a public offering price of US$4.25 per common share. The common shares commenced trading on November 7, 2024, under the ticker symbol “ADUR.”

D. Boral Capital projected 2024 revenues to be ~$100M, along with unaudited current net income of ~$25M with no debt & strongest balance sheet since inception

NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- D. Boral Capital, a relationship & performance driven investment bank focused on growth issuers and their investors, today announces it will be a Platinum sponsor of The PIPEs Conference (A DealFlow Event) being held November 13-14, 2024 at the Hard Rock Hotel & Casino in Hollywood, Fla.